{
  "nctId": "NCT03405493",
  "briefTitle": "Sleep, Wake and Light Therapy for Depression",
  "officialTitle": "Sleep, Wake and Light Therapy for Depression",
  "protocolDocument": {
    "nctId": "NCT03405493",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2017-07-01",
    "uploadDate": "2018-01-11T08:14",
    "size": 1039066,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03405493/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "SINGLE",
  "enrollmentInfo": {
    "enrollmentCount": 60,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2018-01-18",
    "completionDate": "2019-09-23",
    "primaryCompletionDate": "2019-09-23",
    "firstSubmitDate": "2018-01-05",
    "firstPostDate": "2018-01-23"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Diagnosis of Depressive Episode (ICD10 F32) or Recurrent Depressive Disorder (F33).\n* Minimum score of 8 or more on the Hamilton Depression Rating Scale (6 item) (Range 0-22) (Bech,1981).\n* Age 18-65\n* Able to give informed consent\n* Women of child bearing age may be included and no methods of contraception is required to enable inclusion into the trial.\n\nExclusion Criteria:\n\n* Current diagnosis of Seasonal Affective Disorder\n* Current diagnosis of anorexia nervosa or bulimia.\n* Current diagnosis of an obsessive compulsive or related disorder\n* Current diagnosis of post-traumatic stress disorder\n* History of schizophrenia, schizoaffective disorder or bipolar disorder\n* Severe cognitive impairment, dementia, intellectual disability or organic brain disorder.\n* History of stimulant or hallucinogenic misuse, alcohol or substance misuse or dependence in past 3 months.\n* Borderline Personality Disorder or other personality disorder considered to be the main problem.\n* Duration of depression more than 2 years.\n* Significant risk of suicide that requires hospitalisation.\n* Severe eye disease or cataracts or traumatic injury or visual impairment affecting both eyes.\n* History of epilepsy, uncontrolled severe headaches, or stroke as this may lower seizure threshold through sleep deprivation.\n* Unstable medical condition that would make wake therapy intolerable\n* Untreated sleep disorder such as obstructive sleep apnoea or narcolepsy\n* Use of photo-sensitizing drugs.\n* Current night-shift work.\n* Non-English speaker.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "65 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Number of participants recruited per month/Adherence to the protocol",
        "description": "To compare the rate of recruitment and adherence to the treatments in both groups",
        "timeFrame": "Week 1"
      }
    ],
    "secondary": [
      {
        "measure": "MINI International Neuropsychiatric Interview Version 5.0",
        "description": "To determine diagnosis by DSM-IV criteria",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Hamilton Depression Rating Scale",
        "description": "To compare the effects on observer rated depressive symptoms in both groups",
        "timeFrame": "Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation"
      },
      {
        "measure": "Clinical Global Impression and Improvement Scale (Guy, 1976)",
        "description": "To compare the effects on observer rated clinical impression in both groups",
        "timeFrame": "Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation"
      },
      {
        "measure": "Quick Inventory of Depressive Symptomatology -SR Version (Triveni et al., 2004) Questionnaire",
        "description": "To compare the effects on subjective depressive symptoms in both groups",
        "timeFrame": "Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation"
      },
      {
        "measure": "Brief Ruminative Response Scale (Topper et al, 2014). Questionnaire",
        "description": "To compare the effects on measures of subjective rumination in both groups",
        "timeFrame": "Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation"
      },
      {
        "measure": "Pittsburgh Sleep Index (Bysse et al., 1999) Questionnaire",
        "description": "To compare the effects on subjective sleep quality in both groups",
        "timeFrame": "Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation"
      },
      {
        "measure": "Euroquol 5D (1990) Questionnaire",
        "description": "To compare the effects on subjective general quality of life in both groups",
        "timeFrame": "Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation"
      },
      {
        "measure": "To check the amount of current antidepressant use",
        "description": "Amount of antidepressant drugs (in mg of antidepressant equivalents) (Hayasaka et al., 2015) or benzodiazepine drugs (in mg of diazepam equivalents)",
        "timeFrame": "Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation"
      },
      {
        "measure": "To check the amount of current psychotherapy use",
        "description": "The amount of Cognitive Behaviour Therapy or any other counselling or psychotherapy (number of hours)",
        "timeFrame": "Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation"
      },
      {
        "measure": "Daily sleep diary",
        "description": "A subjective measure of total sleep time",
        "timeFrame": "3 days pre-randomisation and 7 days post-randomisation"
      },
      {
        "measure": "Credibility and Expectancy Questionnaire (Devilly, 2000).",
        "description": "A measure of the credibility of the intervention",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Morning/Evening Questionnaire",
        "description": "A measure of morning/evening preference",
        "timeFrame": "3 days pre-randomisation"
      },
      {
        "measure": "Wrist actigraph from GeneActiv daily (Physiological parameter)",
        "description": "A measure of the sleep/wake activity, which correlates with the gold standard of sleep physiology (polysomnography).",
        "timeFrame": "3 days pre-randomisation and 7 days post-randomisation."
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 13,
      "otherCount": 0,
      "totalCount": 14
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 100,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:29:19.425Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}